Patents by Inventor Robert Galyean

Robert Galyean has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • V1A receptor agonists
    Patent number: 9388214
    Abstract: Compounds of formula (I), salts thereof, and compositions and uses thereof are described. The compounds are useful as V1a vasopressin agonists, for the treatment of, e.g., complications of cirrhosis, including bacterial peritonitis, HRS2 and refractory ascites.
    Type: Grant
    Filed: November 5, 2014
    Date of Patent: July 12, 2016
    Assignee: Ferring B.V.
    Inventors: Kazimierz Wisniewski, Geoffrey S. Harris, Robert Galyean
  • V1A RECEPTOR AGONISTS
    Publication number: 20160122386
    Abstract: Compounds of formula (I), salts thereof, and compositions and uses thereof are described. The compounds are useful as V1a vasopressin agonists, for the treatment of, e.g., complications of cirrhosis, including bacterial peritonitis, HRS2 and refractory ascites.
    Type: Application
    Filed: November 5, 2014
    Publication date: May 5, 2016
    Inventors: Kazimierz Wisniewski, Geoffrey S. Harris, Robert Galyean
  • Oxytocin receptor agonists
    Patent number: 8748564
    Abstract: The present invention relates to oxytocin receptor agonist compounds, pharmaceutical compositions comprising the same, use of such compounds for the manufacture of a medicament for treatment of inter alia, abdominal pain, irritable bowel syndrome (IBS), autism, erectile dysfunction, female sexual dysfunction, labor induction and maintenance, lactation induction and maintenance, postpartum hemorrhage, Post Traumatic Stress Disorder (PTSD), pain, anxiety and other conditions, as well as to methods for the treatment of such conditions, wherein such compounds are administered.
    Type: Grant
    Filed: September 21, 2010
    Date of Patent: June 10, 2014
    Assignee: Ferring B.V.
    Inventors: Kazimierz Wisniewski, Claudio Daniel Schteingart, Sudarkodi Alagarsamy, Robert Galyean
  • Oxytocin analogues
    Patent number: 8673841
    Abstract: The present invention relates to novel compounds, pharmaceutical compositions comprising the same, use of said compounds for the manufacture of a medicament for treatment of inter alia compromised lactation conditions as well as to a method for treatment of said conditions, wherein said compounds are administered. The compounds are represented by the general formula (I), as further defined in the specification.
    Type: Grant
    Filed: March 30, 2009
    Date of Patent: March 18, 2014
    Assignee: Ferring B.V.
    Inventors: Sudar Alagarsamy, Robert Galyean, Kaszimierz Wisniewski, Claudio Schteingart
  • OXYTOCIN RECEPTOR AGONISTS
    Publication number: 20120214733
    Abstract: The present invention relates to oxytocin receptor agonist compounds, pharmaceutical compositions comprising the same, use of such compounds for the manufacture of a medicament for treatment of inter alia, abdominal pain, irritable bowel syndrome (IBS), autism, erectile dysfunction, female sexual dysfunction, labor induction and maintenance, lactation induction and maintenance, postpartum hemorrhage, Post Traumatic Stress Disorder (PTSD), pain, anxiety and other conditions, as well as to methods for the treatment of such conditions, wherein such compounds are administered.
    Type: Application
    Filed: September 21, 2010
    Publication date: August 23, 2012
    Applicant: FERRING INTERNATIONAL CENTER S.A.
    Inventors: Kazimierz Wisniewski, Claudio Daniel Schteingart, Sudarkodi Alagarsamy, Robert Galyean
  • OXYTOCIN ANALOGUES
    Publication number: 20110044905
    Abstract: The present invention relates to novel compounds, pharmaceutical compositions comprising the same, use of said compounds for the manufacture of a medicament for treatment of inter alia compromised lactation conditions as well as to a method for treatment of said conditions, wherein said compounds are administered. The compounds are represented by the general formula (I), as further defined in the specification.
    Type: Application
    Filed: March 30, 2009
    Publication date: February 24, 2011
    Applicant: Ferring B.V.
    Inventors: Sudar Alagarsamy, Robert Galyean, Kazimierz Wisniewski, Claudio Schteingart